Gordon Kuntz has almost 20 years of experience working in the cancer space for a variety of companies directly and as a consultant. He currently consults with pharma manufacturers and technology companies to provide strategic advice on issues that impact and influence market access, including pathways, quality and value programs, practice economics, and payer perspectives. Since 2020 he has worked with Janssen Oncology on issues of quality, value-based care, and oncology pathways.
Since 2004, Gordon has worked with oncology clinical pathways for a variety of organizations, including US Oncology, ION Solutions/AmerisourceBergen, Via Oncology (now Elsevier), a large NCI Cancer Center with its own pathways, and multiple pharmaceutical manufacturers. A member of the editorial board of the Journal of Clinical Pathways, he has contributed numerous articles and has moderated the Oncology Clinical Pathways Congress since 2019. Gordon hosts the video podcast series Oncology Innovations and is a frequent speaker on oncology clinical pathways and the cancer care ecosystem.